|
注册号: Registration number: |
ChiCTR2600125804 |
|
最近更新日期: Date of Last Refreshed on: |
2026-06-01 09:37:46 |
|
注册时间: Date of Registration: |
2026-06-01 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于健康信念模型的脑卒中患者跌倒恐惧风险沟通方案的构建与应用 |
|
Public title: |
Construction and Application of a Fear of Falling Risk Communication Program for Stroke Patients Based on the Health Belief Model |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于健康信念模型的脑卒中患者跌倒恐惧风险沟通方案的构建与应用 |
|
Scientific title: |
Construction and Application of a Fear of Falling Risk Communication Program for Stroke Patients Based on the Health Belief Model |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈艳蕊 |
研究负责人: |
陈艳蕊 |
|
Applicant: |
Chen Yanrui |
Study leader: |
Chen Yanrui |
|
申请注册联系人电话: Applicant telephone: |
+86 158 3342 4869 |
研究负责人电话:
Study leader's |
+86 158 3342 4869 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
18231233621@163.com |
研究负责人电子邮件: Study leader's E-mail: |
18231233621@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
河北省定州市军工路389号 |
研究负责人通讯地址: |
河北省定州市军工路389号 |
|
Applicant address: |
No. 389 Jungong Road, Dingzhou City, Hebei Province, China |
Study leader's address: |
No. 389 Jungong Road, Dingzhou City, Hebei Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
河北省第七人民医院 |
||
|
Applicant's institution: |
The Seventh People's Hospital of Hebei Province |
||
|
研究负责人所在单位: |
河北省第七人民医院 |
||
|
Affiliation of the Leader: |
The Seventh People's Hospital of Hebei Province |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2026-HXKY-004-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
河北省第七人民医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of the Seventh People's Hospital of Hebei Province |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-04-06 00:00:00 | ||
|
伦理委员会联系人: |
赵家宁 |
||
|
Contact Name of the ethic committee: |
Zhao Jianing |
||
|
伦理委员会联系地址: |
河北省定州市军工路389号 |
||
|
Contact Address of the ethic committee: |
No. 389 Jungong Road, Dingzhou City, Hebei Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 312 235 7871 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
河北省第七人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Seventh People's Hospital of Hebei Province |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
河北省定州市军工路389号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 389 Jungong Road, Dingzhou City, Hebei Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-funded |
||||||||||||||||||||||
|
研究疾病: |
脑卒中 |
||||||||||||||||||||||
|
Target disease: |
stroke |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
基于健康信念模型为基础,构建风险沟通方案,探讨风险沟通对脑卒中患者跌倒恐惧的干预效果,验证该方案对改善脑卒中患者跌倒恐惧的有效性和可行性。 |
||||||||||||||||||||||
|
Objectives of Study: |
aking the Health Belief Model as the theoretical basis, this study developed a risk communication protocol, explored its intervention effects on fear of falling in stroke patients, and verified the effectiveness and feasibility of the protocol for relieving fear of falling among stroke survivors. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.合并肌肉骨骼和神经系统疾病(例如骨折、严重骨质疏松症、帕金森病和脊髓损伤)造成的活动障碍; 2.合并严重心、肺、肝、肾等疾病而活动受限; 3.严重失语、认知障碍、精神异常等不能配合者; 4.正在参与可能影响本研究结果评价的其他临床试验者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Activity limitations caused by combined musculoskeletal and nervous system diseases (such as fractures, severe osteoporosis, Parkinson's disease, and spinal cord injuries); 2. Activity restrictions due to severe heart, lung, liver, kidney, and other diseases; 3. Those who cannot cooperate due to severe aphasia, cognitive impairment, or mental disorders; 4. Participants currently involved in other clinical trials that may affect the evaluation of this study's results. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-06-01 00:00:00至 To 2027-04-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-06-01 00:00:00 至 To 2027-04-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机数字表法 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
random number table method |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
none |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |